Emalex Biosciences develops treatments for central nervous system movement disorders and fluency disorders. Our current focus is developing ecopipam, an investigational medicine, for Tourette Syndrome and stuttering.
Emalex Biosciences develops treatments for central nervous system movement disorders and fluency disorders. Our current focus is developing ecopipam, an investigational medicine, for Tourette Syndrome and stuttering.
